Treatment of myeloma
Le Chevallier, P.L.
La Semaine des Hopitaux Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 47(4): 249-251
1971
ISSN/ISBN: 0037-1777 PMID: 4322132 Document Number: 36260
Document emailed within 1 workday
Related Documents
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Leinonen, P.; Somer, T. 1988: Light-chain myeloma and non-secretory myeloma--problems in di- agnosis and associated paraproteins Duodecim; Laaketieteellinen Aikakauskirja 104(18): 1466-1470
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Wu, M-Jei.; Fang, H-Chang.; Chang, T-Yuan.; Lo, Y-Shing.; Chung, H-Min. 2002: Multiple myeloma with myeloma nephropathy in a patient with Hashimoto's thyroiditis Journal of the Formosan Medical Association 101(6): 421-424
G.Mead, P.; H.D. Carr-Smith; M.Drayson, T.; A.R. Bradwell 2003: Detection of Bence Jones Myeloma and Monitoring of Myeloma Chemotherapy UsingImmunoassays Specific for Free Immunoglobulin Light Chains Clinical Laboratory 49(1-2): 25-27
Brouet, J.C. 1993: Treatment of multiple myeloma La Revue du Praticien 43(3): 321-325
Verevkin, I.N. 1981: Treatment of myeloma disease Meditsinskaia Sestra 40(11): 5-7
Bauters, F. 1972: Myeloma: diagnosis and treatment Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 17(7): 1032-1040
Berenson, J.R. 2012: Updates in the treatment of multiple myeloma Clinical Advances in Hematology and Oncology: H&o 10(10): 667-669
Tomita, S.; Okamoto, S. 2007: Role of interferon for the treatment of myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 65(12): 2285-2290
Nau, K.C.; Lewis, W.D. 2008: Multiple myeloma: diagnosis and treatment American Family Physician 78(7): 853-859
Riccardi, A.; Merlini, G.; Montecucco, C.; Perugini, S. 1980: Vincristine in the treatment of multiple myeloma Haematologica 65(5): 595-611
Fermand, J.P.; Ravaud, P. 1997: Treatment of myeloma: role of intensive treatments Presse Medicale 26(11): 521-524
Demina, E.A.; Votiakova, O.M. 1996: Alpha-interferon in present-day treatment of myeloma Gematologiia i Transfuziologiia 41(2): 32-36
Lokhorst, H.M.; Sonneveld, P.; Wijermans, P.W.; Segeren, C.M. 1998: Multiple myeloma; treatment in the year 1998 Nederlands Tijdschrift Voor Geneeskunde 142(28): 1596-1602
Murakami, H.; Saito, T.; Handa, H. 2013: I. Proteasome inhibitor for treatment of multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(5): 583-588
2009: Treatment of multiple myeloma: 2009 update Prescrire international 18(104): 263-266
Mendez-Lopez, M.; Sutter, T.; Driessen, C.; Besse, L. 2019: HIV protease inhibitors for the treatment of multiple myeloma Clinical Advances in Hematology and Oncology: H&o 17(11): 615-623
Piatkowska-Jakubas, B.; Skotnicki, A.B.; Blicharski, J. 1988: Possibility of using interferon in the treatment of multiple myeloma Przeglad Lekarski 45(10): 747-750